MarketInOut Stock Screener Log In | Sign Up

Cann Group Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 11/04/2026 15:51
Cann Group Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization8.3 mln
Float1,660 mln
Earnings Date02/26/2027

EPS

0.02
Marginal

P / E

0.25
Anomalous

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-0.87
Highly suspicious

Relative Strength

67 / 100
Outperforming

Debt / Equity

0.57
Moderate leverage

Business Description

Founded in 2014 and headquartered in Mildura, Australia, Cann Group grows and produces cannabis-based medicines for patients in Australia and Europe. The company sells these products under its own brand and also offers Satipharm, a specialized system designed to deliver cannabinoids to the body more effectively.

Key Fundamentals

EPS0.02
P/E0.25
ROE103
RPS0.01
ROIC-13.92
ROA33.21
Interest Cover-2.20
EBITDA, mln31.84
EV / EBITDA0.77
EV / EBIT0.94
Revenue, mln8.56
EV / Revenue2.85

Quote Details

Last 0.005
Change 0 (0%)
Open 0.005
Volume 1,414,913
Turnover 7,074.56
Average Volume 2,491,264

Financial Ratios

Pre-Tax Profit Margin241
Leverage Ratio1.82
Current Ratio0.98
Price / Book0.23
Price / Tangible Book0.20
Debt / Equity0.57
Price / Sales0.57

Financial Strength

Altman Z-Score-2.55
Piotroski F-Score 4 / 9
Beneish M-Score-0.87

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 25% 99 / 100   
1 Month -16.67% 28 / 100   
2 Months 150% 100 / 100   
6 Months 0% 62 / 100   
1 Year -50% 19 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog